Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation

Bibliography

• Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719-40
   PubMed Web of Science ®Google Scholar
• Baell JB. Observations on screening-based research and some concerning trends in the literature. Future Med Chem 2010;2:1529-46
   PubMed Web of Science ®Google Scholar
• Mendgen T, Steuer C, Klein CD. Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry. J Med Chem 2012;55:743-53
   PubMed Web of Science ®Google Scholar
• Tomasic T, Masic LP. Rhodanine as a privileged scaffold in drug discovery. Curr Med Chem 2009;16:1596-629
   PubMed Web of Science ®Google Scholar
• Terashima H, Hama K, Yamamoto R, Effects of a new aldose reductase inhibitor on various tissues in vitro. J Pharmacol Exp Ther 1984;229:226-30
   PubMed Web of Science ®Google Scholar
• Chen ZH, Zheng CJ, Sun LP, Piao HR. Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity. Eur J Med Chem 2010;45:5739-43
   PubMed Web of Science ®Google Scholar
• Hardej D, Ashby CR Jr, Khadtare NS, The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains. Eur J Med Chem 2010;45:5827-32
   PubMed Web of Science ®Google Scholar
• Tomasic T, Zidar N, Mueller-Premru M, Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones. Eur J Med Chem 2010;45:1667-72
   PubMed Web of Science ®Google Scholar
• Silver LL. Challenges of antibacterial discovery. Clin Microbiol Rev 2011;24:71-109
   PubMed Web of Science ®Google Scholar
• Aiello D, Barnes MH, Biswas EE, Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases. Bioorg Med Chem 2009;17:4466-76
   PubMed Web of Science ®Google Scholar
• Tomasic T, Zidar N, Rupnik V, Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase. Bioorg Med Chem Lett 2009;19:153-7
   PubMed Web of Science ®Google Scholar
• Zidar N, Tomasic T, Sink R, Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. J Med Chem 2010;53:6584-94
   PubMed Web of Science ®Google Scholar
• Zidar N, Tomasic T, Sink R, New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation. Eur J Med Chem 2011;46:5512-23
   PubMed Web of Science ®Google Scholar
• Tomasic T, Zidar N, Sink R, Structure-based design of a new series of D-glutamic acid based inhibitors of bacterial UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD). J Med Chem 2011;54:4600-10
   PubMed Web of Science ®Google Scholar
• Tomasic T, Zidar N, Kovac A, 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases. ChemMedChem 2010;5:286-95
   PubMed Web of Science ®Google Scholar
• Tomasic T, Kovac A, Simcic M, Novel 2-thioxothiazolidin-4-one inhibitors of bacterial MurD ligase targeting D-Glu- and diphosphate-binding sites. Eur J Med Chem 2011;46:3964-75
   PubMed Web of Science ®Google Scholar
• Suree N, Yi SW, Thieu W, Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors. Bioorg Med Chem 2009;17:7174-85
   PubMed Web of Science ®Google Scholar
• Beuria TK, Singh P, Surolia A, Panda D. Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs. Biochem J 2009;423:61-9
   PubMed Web of Science ®Google Scholar
• Talele TT, Arora P, Kulkarni SS, Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem 2010;18:4630-8
   PubMed Web of Science ®Google Scholar
• Katritzky AR, Tala SR, Lu H, Design, synthesis, and structure-activity relationship of a novel series of 2-aryl 5-(4-oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 entry inhibitors. J Med Chem 2009;52:7631-9
   PubMed Web of Science ®Google Scholar
• He XY, Zou P, Qiu J, Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors. Bioorg Med Chem 2011;19:6726-34
   PubMed Web of Science ®Google Scholar
• Maga G, Falchi F, Radi M, Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation. ChemMedChem 2011;6:1371-89
   PubMed Web of Science ®Google Scholar
• Havrylyuk D, Mosula L, Zimenkovsky B, Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur J Med Chem 2010;45:5012-21
   PubMed Web of Science ®Google Scholar
• Moorthy BT, Ravi S, Srivastava M, Novel rhodanine derivatives induce growth inhibition followed by apoptosis. Bioorg Med Chem Lett 2010;20:6297-301
   PubMed Web of Science ®Google Scholar
• Li W, Zhai X, Zhong Z, Design, synthesis and evaluation of novel rhodanine-containing sorafenib analogs as potential antitumor agents. Arch Pharm 2011;344:349-57
   Web of Science ®Google Scholar
• Bernardo PH, Sivaraman T, Wan KF, Structural insights into the design of small molecule inhibitors that selectively antagonize Mcl-1. J Med Chem 2010;53:2314-18
   PubMed Web of Science ®Google Scholar
• Lugovskoy AA, Degterev AI, Fahmy AF, A novel approach for characterizing protein ligand complexes: molecular basis for specificity of small-molecule Bcl-2 inhibitors. J Am Chem Soc 2002;124:1234-40
   PubMed Web of Science ®Google Scholar
• Park H, Jung SK, Yu KR, Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties. Chem Biol Drug Des 2011;78:642-50
   PubMed Web of Science ®Google Scholar
• Harada K, Kubo H, Tanaka A, Nishioka K. Identification of oxazolidinediones and thiazolidinediones as potent 17beta-hydroxysteroid dehydrogenase type 3 inhibitors. Bioorg Med Chem Lett 2012;22:504-7
   PubMed Web of Science ®Google Scholar
• Strittmatter T, Bareth B, Immel TA, Small molecule inhibitors of human DNA polymerase lambda. ACS Chem Biol 2011;6:314-19
   PubMed Web of Science ®Google Scholar
• van Delft MF, Wei AH, Mason KD, The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006;10:389-99
   PubMed Web of Science ®Google Scholar
• Heng S, Tieu W, Hautmann S, New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds. Bioorg Med Chem 2011;19:7453-63
   PubMed Web of Science ®Google Scholar
• Carroll RT, Dluzen DE, Stinnett H, Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B. Bioorg Med Chem Lett 2011;21:4798-803
   PubMed Web of Science ®Google Scholar
• Maccari R, Del Corso A, Giglio M, In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. Bioorg Med Chem Lett 2011;21:200-3
   PubMed Web of Science ®Google Scholar
• La Pietra V, Marinelli L, Cosconati S, Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization. Eur J Med Chem 2012;47:143-52
   PubMed Web of Science ®Google Scholar
• Kopeikin Z, Sohma Y, Li M, Hwang TC. On the mechanism of CFTR inhibition by a thiazolidinone derivative. J Gen Physiol 2010;136:659-71
   PubMed Web of Science ®Google Scholar
• Manuvakhova MS, Johnson GG, White MC, Identification of novel small molecule activators of nuclear factor-kappaB with neuroprotective action via high-throughput screening. J Neurosci Res 2011;89:58-72
   PubMed Web of Science ®Google Scholar
• Lesyk RB, Zimenkovsky BS. 4-thiazolidones: centenarian history, current status and perspectives for modern organic and medicinal chemistry. Curr Org Chem 2004;8:1547-77
   Web of Science ®Google Scholar
• Sink R, Gobec S, Pecar S, Zega A. False positives in the early stages of drug discovery. Curr Med Chem 2010;17:4231-55
   PubMed Web of Science ®Google Scholar
• Babaoglu K, Simeonov A, Irwin JJ, Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase. J Med Chem 2008;51:2502-11
   PubMed Web of Science ®Google Scholar
• McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002;45:1712-22
   PubMed Web of Science ®Google Scholar
• McGovern SL, Helfand BT, Feng B, Shoichet BK. A specific mechanism of nonspecific inhibition. J Med Chem 2003;46:4265-72
   PubMed Web of Science ®Google Scholar
• Powers JP, Piper DE, Li Y, SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. J Med Chem 2006;49:1034-46
   PubMed Web of Science ®Google Scholar
• Carlson EE, May JF, Kiessling LL. Chemical probes of UDP-galactopyranose mutase. Chem Biol 2006;13:825-37
   PubMed Web of Science ®Google Scholar
• Huth JR, Mendoza R, Olejniczak ET, ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc 2005;127:217-24
   PubMed Web of Science ®Google Scholar
• Huth JR, Song D, Mendoza RR, Toxicological evaluation of thiol-reactive compounds identified using a La assay to detect reactive molecules by nuclear magnetic resonance. Chem Res Toxicol 2007;20:1752-9
   PubMed Web of Science ®Google Scholar
• Carter PH, Scherle PA, Muckelbauer JK, Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha. Proc Natl Acad Sci USA 2001;98:11879-84
   PubMed Web of Science ®Google Scholar
• Forino M, Johnson S, Wong TY, Efficient synthetic inhibitors of anthrax lethal factor. Proc Natl Acad Sci USA 2005;102:9499-504
   PubMed Web of Science ®Google Scholar
• Georgescu RE, Yurieva O, Kim SS, Structure of a small-molecule inhibitor of a DNA polymerase sliding clamp. Proc Natl Acad Sci USA 2008;105:11116-21
   PubMed Web of Science ®Google Scholar
• Cerchietti LC, Ghetu AF, Zhu X, A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. Cancer Cell 2010;17:400-11
   PubMed Web of Science ®Google Scholar
• Wu J, Tao Y, Zhang M, Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region. J Biol Chem 2007;282:22185-94
   PubMed Web of Science ®Google Scholar
• Grant EB, Guiadeen D, Baum EZ, The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors. Bioorg Med Chem Lett 2000;10:2179-82
   PubMed Web of Science ®Google Scholar
• Villain-Guillot P, Gualtieri M, Bastide L, Structure-activity relationships of Phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms. J Med Chem 2007;50:4195-204
   PubMed Web of Science ®Google Scholar
• Allen FH, Bird CM, Rowland RS, Raithby PR. Resonance-induced hydrogen bonding at sulfur acceptors in R1R2C=C and R1CS2- systems. Acta Crystallogr B 1997;53:680-95
   Web of Science ®Google Scholar
• Wood PA, Pidcock E, Allen FH. Interaction geometries and energies of hydrogen bonds to C = O and C = S acceptors: a comparative study. Acta Crystallogr B 2008;64:491-6
   PubMed Web of Science ®Google Scholar
• Karanam BV, Hop CE, Liu DQ, In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterases. Drug Metab Dispos 2004;32:1015-22
   PubMed Web of Science ®Google Scholar
• Reddy VB, Karanam BV, Gruber WL, Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols. Chem Res Toxicol 2005;18:880-8
   PubMed Web of Science ®Google Scholar
• Saha S, New LS, Ho HK, Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity. Toxicol Lett 2010;192:141-9
   PubMed Web of Science ®Google Scholar
• Mansuy D, Dansette PM. Sulfenic acids as reactive intermediates in xenobiotic metabolism. Arch Biochem Biophys 2011;507:174-85
   PubMed Web of Science ®Google Scholar
• Cutshall NS, O’Day C, Prezhdo M. Rhodanine derivatives as inhibitors of JSP-1. Bioorg Med Chem Lett 2005;15:3374-9
   PubMed Web of Science ®Google Scholar
• French KJ, Schrecengost RS, Lee BD, Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003;63:5962-9
   PubMed Web of Science ®Google Scholar
• Hu Y, Helm JS, Chen L, Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening. Chem Biol 2004;11:703-11
   PubMed Web of Science ®Google Scholar
• Degterev A, Lugovskoy A, Cardone M, Identification of small-molecule inhibitors of the interaction between the BH3 domain and Bcl-xL. Nat Cell Biol 2001;3:173-82
   PubMed Web of Science ®Google Scholar
• Pymol is available from Delano Scientific LLC, San Francisco, CA. Available from: http://pymol.sourceforge.net
   Google Scholar